Semaglutide, 0.5 mg/mL

DRUG3 trials

Sponsors

Novo Nordisk A/S, University of Oxford, Bispebjerg Hospital

Conditions

Cognitive ChangeDiabetes Mellitus, Type 2Kidney Disease, Chronic

Phase 1

A Research Study to Look at Similarity Between Semaglutide Versions in Different Injection Tools

CompletedNCT03598621

Novo Nordisk A/SDiabetes Mellitus, Type 2

Start: 2018-07-23End: 2019-01-17Updated: 2020-01-09

Unknown Phase

Semaglutide and Cognition in Healthy Volunteers

CompletedNCT06363487

University of OxfordCognitive Change

Start: 2024-06-06End: 2024-12-11Updated: 2025-06-06

Semaglutide's Effect on Renal Hemodynamics and Function in Patients With Type 2 Diabetes Mellitus and Nephropathy

Not yet recruitingNCT06555146

Bispebjerg HospitalDiabetes Mellitus, Type 2, Kidney Disease, Chronic

Start: 2024-08-31End: 2025-03-31Target: 15Updated: 2024-08-15